STEPHANIE DOUGLASS: Open Payments
NPI 1386904803 · OLIVE BRANCH, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$481 in 27 payments from 10 companies in 2025. Trend: 2023 $434 · 2024 $177 · 2025 $481
Food & beverage: $481
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 8 | $144 |
| ABBVIE INC. | 3 | $65 |
| Vanda Pharmaceuticals Inc. | 3 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Alkermes, Inc. | 2 | $42 |
| Corium, LLC | 2 | $35 |
| Janssen Pharmaceuticals, Inc | 2 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $30 |
| Collegium Pharmaceutical, Inc. | 2 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: Qelbree, VRAYLAR, FANAPT, ARISTADA, Azstarys, INVEGA SUSTENNA, CAPLYTA, Jornay PM.
Industry payments across MS — which companies pay providers there.
